These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19288855)

  • 21. [Protective effect and antibody titer of intravenous immunoglobulin (IVIG) against clinical isolates of opportunistic bacteria].
    Nakae T; Nakajima T; Nagai H; Watanabe M; Yokoyama K
    Yakugaku Zasshi; 1994 Dec; 114(12):972-9. PubMed ID: 7869237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IV Immunoglobulin for Acute Lung Injury and Bacteremia in Pseudomonas aeruginosa Pneumonia.
    Katoh H; Yasumoto H; Shimizu M; Hamaoka S; Kinoshita M; Akiyama K; Sawa T
    Crit Care Med; 2016 Jan; 44(1):e12-24. PubMed ID: 26317571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.
    Schiller NL; Alazard MJ; Borowski RS
    Infect Immun; 1984 Sep; 45(3):748-55. PubMed ID: 6432698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bactericidal activity of normal human serum against Enterobacteriaceae rods with lipopolysaccharides possessing O-antigens composed of mannan.
    Tichaczek-Goska D; Witkowska D; Cisowska A; Jankowski S; Hendrich AB
    Adv Clin Exp Med; 2012; 21(3):289-99. PubMed ID: 23214191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A complement-sensitive mutant of Pseudomonas aeruginosa.
    Offredo-Hemmer C; Berche P; Véron M
    Ann Microbiol (Paris); 1983; 134A(3):281-94. PubMed ID: 6416122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN.
    Piepers S; Jansen MD; Cats EA; van Sorge NM; van den Berg LH; van der Pol WL
    J Neuroimmunol; 2010 Dec; 229(1-2):256-62. PubMed ID: 20920831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. II. In vitro bactericidal and opsonophagocytic studies with specific antiserum.
    Lieberman MM; Frank WJ; Brady AV
    J Surg Res; 1988 Mar; 44(3):251-8. PubMed ID: 3125389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N; Olling S
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa.
    Pepeljnjak S; Kosalec I
    FEMS Microbiol Lett; 2004 Nov; 240(1):111-6. PubMed ID: 15500987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK
    APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High dose intravenous immunoglobulin does not affect complement-bacteria interactions.
    Wagner E; Platt JL; Frank MM
    J Immunol; 1998 Feb; 160(4):1936-43. PubMed ID: 9469456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance.
    Basta M; Langlois PF; Marques M; Frank MM; Fries LF
    Blood; 1989 Jul; 74(1):326-33. PubMed ID: 2752117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
    Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
    Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa.
    Lang BJ; Aaron SD; Ferris W; Hebert PC; MacDonald NE
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2241-5. PubMed ID: 11112146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies.
    Morrin M; Reen DJ
    J Med Microbiol; 1993 Dec; 39(6):459-66. PubMed ID: 8246266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.